Press Releases
-
GenNext & SCIEX to Co-Market an Advanced High Order Structure Analysis (HOS) Workflow for Biopharmaceutical Research
GenNext Technologies, Inc. has revealed their agreement to co-market a robust, full-solution workflow for Hydroxyl Radical Protein Footprinting studies with SCIEX.
Sep 5, 2023
-
Blue Spark Technologies Adds Amir Lahav to Key Opinion Leader Advisory Group
Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, has added Amir Lahav, a clinical leader and established neuroscientist with 20 years of experience to its advisory board.
Aug 28, 2023
-
CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service
-
CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service
-
Dr. Vince Clinical Research, Clario Form Strategic Partnership to Deliver Innovative Cardiac Assessments in Clinical Trials
Dr. Vince Clinical Research (DVCR), an early phase Clinical Research Organization (CRO), today announced a new collaboration with Clario, a leading healthcare research and technology company that delivers leading endpoint technology solutions for clinical trials.
Aug 28, 2023
-
Barry Simms Named as Elligo Health Research’s Chief Operating Officer
Elligo Health Research®, the largest healthcare-enabling research organization, today announced the addition of Barry Simms as Elligo’s Chief Operating Officer (COO). Simms’ expertise in global strategy and partnerships will help further the company’s growth and mission of providing everyone with easy access to participation in research and to accelerate clinical trials along the way.
Aug 28, 2023
-
CD Genomics Launches Mature HLA Typing Solutions Enabling Precision Immune Profiling
-
Breaking Ground: CD Formulation announces 90+ Active Pharmaceutical Ingredients Lineup
-
Kiora Pharmaceuticals Granted U.S. and European Patents for Local Ocular Delivery of the KIO-100 Family of Compounds; New IP Specifically Includes Treatment of Posterior Non-Infectious Uveitis
Kiora Pharmaceuticals, a clinical-stage biotechnology company developing products for the treatment of orphan retinal diseases, has been granted U.S. and European Patents for the local ocular delivery of the company’s non-steroidal, anti-inflammatory small molecules covering several inflammatory-related therapeutic applications including posterior non-infectious uveitis – a debilitating autoimmune disease characterized by inflammation of the retina, choroid, vitreous, or optic nerve that can lead to severe vision loss if left untreated.
Aug 22, 2023
-
ACS BrightEdge Poised to Help Improve 1.5 Million Lives By Investing in Cancer-Focused Therapies and Technologies
American Cancer Society's impact venture fund announces annual results and new framework that measures investments' impact on mission to end cancer
Aug 15, 2023
-
Alfa Chemistry Leads the Way in Tailored Preclinical Drug Research Solutions
-
Creative Proteomics Launches Advanced Exosome Isolation and Purification Service
-
Exploring New Frontiers in Drug Delivery: CD Formulation Introduces State-of-the-Art Microsphere and Microneedle Technologies
-
Creative Proteomics Debuts Far-Western Blot Analysis Service to Advance Proteomics Research
-
Alfa Chemistry Launches a New Blog Section: Sharing Chemical Uses, Chemistry Information and News
-
Katie Coleman promoted to Head of Ashfield Event Experiences US, part of Inizio Engage XD
-
Biopharma PEG Supplies High Quality Cholesterol (Plant-Derived)
About us Biopharma PEG Scientific Inc. is a biotechnology-oriented company in Watertown, Massachusetts. We are dedicated to manufacturing and supplying high purity monodispersed and polydispersed polyethylene glycol (PEG) derivatives and PEG raw material, PEGylation services, and custom PEG derivative synthesis to clients worldwide. We continuously expand the capability to provide large-scale manufacture of high purity PEG derivatives with an extensive variety of functional groups, in both non-GMP and GMP grade. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/
Aug 20, 2023
-
HONEYWELL AND RECIPHARM TO SPEED DEVELOPMENT OF INHALERS WITH A NEAR-ZERO GLOBAL WARMING POTENTIAL PROPELLANT
Partnership to reduce environmental footprint of inhalers
Aug 21, 2023
-
Evoke launches audience intelligence offering to unlock the full commercial potential of life sciences brands
Leading global health and life science brand Evoke has launched a major new audience intelligence service offering to benefit their roster of international pharma and life science clients.
Aug 16, 2023
-
Hyfe AI and ActiGraph Partner to Revolutionize Clinical Trials with AI-Powered Cough Detection
Hyfe's technology integrated into ActiGraph’s new FDA-cleared LEAP wearable device that will advance the use of remote patient monitoring in chronic cough clinical research.
Aug 15, 2023